Home  /  Resource Library  /  Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

Long term results of a trial investigating Ofatumumab maintenance for treatment of relapsed CLL.